文献速递口腔黏膜病

口腔黏膜炎:先天免疫更新与干预新靶点

Oral Mucositis: An Update on Innate Immunity and New Interventional Targets.
PubMed 文献 · J Dent Res · 2020-06-01

本文综述放化疗诱导口腔黏膜炎的病理生物学机制,重点阐述先天免疫主导的炎症级联反应、口腔微生物组失调与组织损伤的交互作用,并探讨针对该严重并发症的新干预靶点。

要点

  • 放化疗诱导的黏膜损伤由先天免疫放大的炎症级联主导并加重。
  • 口腔微生物组失调与宿主免疫信号交互,参与黏膜炎进展与严重度。
  • 综述提出针对先天免疫通路的新干预靶点用于管理口腔黏膜炎。

核心结论

  • 放化疗诱导口腔黏膜炎的病理生物学涉及组织破坏、炎症浸润与口腔微生物组的交互,先天免疫主导的炎症级联是核心调控网络。

研究设计与样本

  • 本文为综述,汇总先天免疫主导的炎症级联在放化疗诱导口腔黏膜炎病理生物学中的机制及新干预靶点。

主要发现

  • 放化疗诱导细胞凋亡引发的口腔黏膜损伤被先天免疫主导的放大炎症级联进一步加重。
  • 口腔黏膜屏障中微生物组与先天免疫组分共存,形成协调环境信号与宿主细胞互作的信号枢纽。
  • 细胞毒性癌症治疗导致口腔微生物群失调,可能促进放化疗诱导口腔黏膜炎的进展与严重度。

临床怎么用

  • 临床可关注先天免疫炎症通路与口腔微生物组互作,作为放化疗口腔黏膜炎管理的新干预方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Oral mucositis (OM), a common debilitating toxicity associated with chemo- and radiation therapies, is a significant unmet clinical need for head and neck cancer patients. The biological complexities of chemoradiotherapy-induced OM involve interactions among disrupted tissue structures, inflammatory infiltrations, and oral microbiome, whereby several master inflammatory pathways constitute the complicated regulatory networks. Oral mucosal damages triggered by chemoradiotherapy-induced cell apoptosis were further exacerbated by the amplified inflammatory cascades dominantly governed by the innate immune responses. The coexistence of microbiome and innate immune components in oral mucosal barriers indicates that a signaling hub coordinates the interaction between environmental cues and host cells during tissue and immune homeostasis. Dysbiotic shifts in oral microbiota caused by cytotoxic cancer therapies may also contribute to the progression and severity of chemoradiotherapy-induced OM. In this review, we have updated the mechanisms involving innate immunity-governed inflammatory cascades in the pathobiology of chemoradiotherapy-induced OM and the development of new interventional targets for the management of this severe morbidity in head and neck cancer patients.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Chen C, Zhang Q, Yu W, et al. Oral Mucositis: An Update on Innate Immunity and New Interventional Targets. J Dent Res. 2020. PMID: 32479139. doi:10.1177/0022034520925421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。